Recent Increase in Meningitis Caused by Neisseria meningitidis Serogroups A and W135, Yaoundé, Cameroon
Open Access
- 1 March 2002
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 8 (3), 327-329
- https://doi.org/10.3201/eid0803.010308
Abstract
From 1991 to 1998, Neisseria meningitidis serogroups A, B, and C represented 2%-10% of strains isolated from cases of bacterial meningitis in Yaoundé. During 1999 to 2000, the percentage of meningococci reached 17%, a proportion never reported since recordkeeping began in 1984. The increase of serogroup A meningococci and the emergence of W135 strains highlight the need for increased surveillance for better diagnosis and prevention.Keywords
This publication has 9 references indexed in Scilit:
- Serogroup W135 meningococcal disease in Hajj pilgrimsThe Lancet, 2000
- Neisseria meningitidis serogroup W135 isolates associated with the ET-37 complex.Emerging Infectious Diseases, 2000
- Meningococcal meningitis in AfricaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1999
- Microevolution through DNA exchange among strains of isolated during an outbreak in the Czech RepublicResearch in Microbiology, 1999
- Meningitis caused by a serogroup W135 clone of the ET‐37 complex of Neisseria meningitidis in West AfricaTropical Medicine & International Health, 1998
- Multilocus sequence typing: A portable approach to the identification of clones within populations of pathogenic microorganismsProceedings of the National Academy of Sciences, 1998
- Epidemics of serogroup ANeisseria meningitidisof subgroup III in Africa, 1989–94Epidemiology and Infection, 1996
- The efficacy of meningococcal polysaccharide vaccine in preventing group A meningococcal disease in The Gambia, West AfricaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1986
- EMERGENCE OF MENINGOCOCCAL MENINGITIS CAUSED BY W135 SEROGROUP IN AFRICAThe Lancet, 1982